HLA-A and hypersensitivity reaction disease: Taking all the cases of CBZ‐induced hypersensitivity reactions (SCAR and DILI) together, the risk of developing either DILI or SCAR when given CBZ was eightfold higher in cases carrying HLA‐A*31:01 (OR = 8.2; 95% CI 4.56–14.66; P = 1.8 × 10−12; Table4).